We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Issues Positive Opinion for AZ’s Tagrisso for Early Access
MHRA Issues Positive Opinion for AZ’s Tagrisso for Early Access
The UK’s Medicines and Healthcare products Regulatory Agency has given its blessing to AstraZeneca's Tagrisso as part of the Early Access to Medicines Scheme.